| Literature DB >> 28163155 |
Bertil Schmidt1, Andreas Hildebrandt2.
Abstract
The progress of next-generation sequencing has a major impact on medical and genomic research. This high-throughput technology can now produce billions of short DNA or RNA fragments in excess of a few terabytes of data in a single run. This leads to massive datasets used by a wide range of applications including personalized cancer treatment and precision medicine. In addition to the hugely increased throughput, the cost of using high-throughput technologies has been dramatically decreasing. A low sequencing cost of around US$1000 per genome has now rendered large population-scale projects feasible. However, to make effective use of the produced data, the design of big data algorithms and their efficient implementation on modern high performance computing systems is required.Entities:
Mesh:
Year: 2017 PMID: 28163155 DOI: 10.1016/j.drudis.2017.01.014
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851